Form 4: Indaptus CFO Nir Sassi Boosts Stake with Share Acquisition

Indaptus Therapeutics' Chief Financial Officer, Nir Sassi, acquired 26,758 shares of common stock at $2.03 per share on December 22, 2025, as part of an employment agreement amendment.

Summary

• Nir Sassi, Chief Financial Officer of Indaptus Therapeutics, Inc. (INDP), acquired 26,758 shares of common stock.
• The transaction occurred on December 22, 2025, at a price of $2.03 per share.
• This acquisition was made pursuant to an amendment to his employment agreement and in connection with a securities purchase agreement dated December 22, 2025.
• Following this transaction, Nir Sassi directly beneficially owns 26,758 shares of Indaptus Therapeutics common stock.
• The total value of the acquired shares is approximately $54,318.74 (26,758 shares * $2.03/share).

Sentiment

Score: 7

Explanation: The acquisition of common stock by the Chief Financial Officer suggests strong insider confidence in the company's future performance and valuation.

Positives

• The Chief Financial Officer acquiring shares indicates confidence in the company's future prospects.
• The acquisition was part of an employment agreement amendment, suggesting alignment of executive incentives with shareholder interests.
• The direct beneficial ownership of 26,758 shares by a key executive strengthens insider alignment.

Future Outlook

This filing does not contain explicit forward-looking statements or guidance. It reports a past transaction.

Industry Context

Insider purchases, especially by a Chief Financial Officer, are often viewed by the market as a signal of management's confidence in the company's valuation and future performance. This transaction aligns the CFO's personal financial interests with those of the shareholders.

Comparison to Industry Standards

• Insider buying is a common occurrence across industries, often seen as a positive indicator. While specific comparable companies or projects are not detailed in this Form 4, the act of an executive increasing their stake is generally interpreted favorably, suggesting they believe the stock is undervalued or has significant upside potential. This aligns with standard market interpretations of insider activity.

Related Party Transactions

• The acquisition of shares by the CFO from the company, pursuant to an employment agreement amendment and securities purchase agreement, constitutes a related party transaction.

Stakeholder Impact

• Shareholders: May view this as a positive signal of management confidence, potentially leading to increased investor interest and a positive impact on share price.
• Employees: May perceive increased stability and alignment within leadership.
• Management: Increased personal stake aligns their interests more closely with long-term company performance.

Key Dates

Recommendation

The insider purchase by the CFO is a positive signal, indicating confidence in the company's future. While not a strong enough signal for an immediate 'buy' recommendation without further fundamental analysis, it suggests a 'hold' is appropriate for existing investors and warrants further investigation for potential new investors, as it implies potential upside.

Keywords

Indaptus Therapeutics, INDP, Nir Sassi, CFO, Insider Trading, Stock Acquisition, Form 4, Beneficial Ownership, Employment Agreement, Securities Purchase Agreement